These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11453542)

  • 1. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.
    Sun HZ; Wu SF; Tu ZH
    Cell Res; 2001 Jun; 11(2):107-15. PubMed ID: 11453542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of IGF-IR by Antisense Oligodeoxynucleotide auguments the sensitivity of bladder cancer cells to mitomycin.
    Sun HZ; Wu SF; Tu ZH
    Acta Pharmacol Sin; 2001 Sep; 22(9):841-6. PubMed ID: 11749868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of IGF1 receptor gene antisense oligodeoxynucleotide on T24 urinary bladder cancer cells].
    Sun H; Fan J; Tang X
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):276-8. PubMed ID: 11778548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
    Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
    Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
    Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
    Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Hu XF; DeLuise M; Zalcberg JR
    Br J Cancer; 1999 Feb; 79(5-6):693-700. PubMed ID: 10070856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells.
    Yuan YL; Zhou XH; Song J; Qiu XP; Li J; Ye LF
    J Laryngol Otol; 2008 Sep; 122(9):952-60. PubMed ID: 17908353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engagement of integrinβ1 induces resistance of bladder cancer cells to mitomycin-C.
    Zhang CJ; Shen ZJ; Pan CW; Zhong S; Li T; Zhang MG
    Urology; 2012 Mar; 79(3):638-43. PubMed ID: 22386417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
    Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced sensitivity to mitomycin C by abating heat shock protein 70 expression in human bladder cancer cell line of BIU-87.
    He LF; Guan KP; Yan Z; Ye HY; Xu KX; Ren L; Hou SK
    Chin Med J (Engl); 2005 Dec; 118(23):1965-72. PubMed ID: 16336832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
    Coppola D; Saunders B; Fu L; Mao W; Nicosia SV
    Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6-P/IGF 2R).
    Pavelić K; Kolak T; Kapitanović S; Radosević S; Spaventi S; Kruslin B; Pavelić J
    J Pathol; 2003 Nov; 201(3):430-8. PubMed ID: 14595755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines.
    Brady G; Crean SJ; Naik P; Kapas S
    Int J Oncol; 2007 Oct; 31(4):875-81. PubMed ID: 17786320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.